Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound

Overview

Journal Breast Cancer (Dove Med Press)

Publisher Dove Medical Press

Date 2021 May 27

PMID 34040436

Citations 8

Authors

Michael Y Chen

William E Gillanders

Affiliations

Soon will be listed here.

Abstract

Axillary lymph nodes have long been recognized as a route for breast cancer to spread systemically. As a result, staging of the axilla has always played a central role in the treatment of breast cancer. Anatomic staging was believed to be important for two reasons: 1) it predicts prognosis and guides medical therapy, and 2) it is a potential therapy for removal of disease in the axilla. This paradigm has now been called into question. Prognostic information is driven increasingly by tumor biology, and trials such as the ACOSOG Z0011 demonstrates removal of axillary disease is not therapeutic. Staging of the axilla has undergone a dramatic de-escalation; however, sentinel lymph node biopsy (SLNB) is still an invasive surgery and represents a large economic burden on the healthcare system. In this review, we outline the changing paradigms of axillary staging in breast cancer from emphasis on anatomic staging to tumor biology, and the evolving role of axillary ultrasound, bringing patients less invasive and more personalized therapy.

Citing Articles

Abnormal Breast Temperature and Cortical Enlargement of the Axillary Lymph Nodes Through the Thermography.

Renero-C F, Martinez-Azmitia T Clin Case Rep. 2024; 12(12):e9636.

PMID: 39677871 PMC: 11638364. DOI: 10.1002/ccr3.9636.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer.

Cao J, Surgeoner B, Manna M, Boileau J, Gelmon K, Brackstone M Curr Oncol. 2024; 31(11):7226-7243.

PMID: 39590163 PMC: 11592626. DOI: 10.3390/curroncol31110533.

Multiparametric ultrasound assessment of axillary lymph nodes in patients with breast cancer.

Dobruch-Sobczak K, Szlenk A, Gumowska M, Maczewska J, Fronczewska K, Lukasiewicz E Sci Rep. 2024; 14(1):23072.

PMID: 39366984 PMC: 11452636. DOI: 10.1038/s41598-024-73376-x.

A case report of synchronous breast and lung cancer with three different pathologic diagnoses.

Khan N, de la Torre M, Moghaddas H, Fromer N, Melnikau S AME Case Rep. 2024; 8:68.

PMID: 39091563 PMC: 11292063. DOI: 10.21037/acr-23-194.

Axillary Management: How Much Is Too Much?.

Owusu-Brackett N, Facer B, Quiroga D, Pariser A, Grimm M, Beyer S Curr Oncol Rep. 2024; 26(7):735-743.

PMID: 38748364 PMC: 11224108. DOI: 10.1007/s11912-024-01539-0.

References

Di Micco R, Zuber V, Fiacco E, Carriero F, Gattuso M, Nazzaro L . Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype. Eur J Surg Oncol. 2019; 45(6):969-975. DOI: 10.1016/j.ejso.2019.01.219. View

Houssami N, Ciatto S, Turner R, Cody 3rd H, Macaskill P . Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg. 2011; 254(2):243-51. DOI: 10.1097/SLA.0b013e31821f1564. View

Engel J, Emeny R, Holzel D . Positive lymph nodes do not metastasize. Cancer Metastasis Rev. 2011; 31(1-2):235-46. DOI: 10.1007/s10555-011-9343-7. View

Whelan T, Olivotto I, Parulekar W, Ackerman I, Chua B, Nabid A . Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015; 373(4):307-16. PMC: 4556358. DOI: 10.1056/NEJMoa1415340. View

Lanng C, Hoffmann J, Galatius H, Engel U . Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer. Eur J Surg Oncol. 2006; 33(3):281-4. DOI: 10.1016/j.ejso.2006.09.032. View

Crigna A, Samec M, Koklesova L, Liskova A, Giordano F, Kubatka P . Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope?. EPMA J. 2020; 11(4):603-627. PMC: 7594983. DOI: 10.1007/s13167-020-00226-x. View

Lucci A, McCall L, Beitsch P, Whitworth P, Reintgen D, Blumencranz P . Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007; 25(24):3657-63. DOI: 10.1200/JCO.2006.07.4062. View

Stemmer S, Steiner M, Rizel S, Geffen D, Nisenbaum B, Peretz T . Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry. NPJ Breast Cancer. 2017; 3:32. PMC: 5591314. DOI: 10.1038/s41523-017-0033-7. View

Qiu S, Zeng H, Zhang F, Chen C, Huang W, Pleijhuis R . A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound. Sci Rep. 2016; 6:21196. PMC: 4753408. DOI: 10.1038/srep21196. View

10.

Hieken T, Boughey J, Jones K, Shah S, Glazebrook K . Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013; 20(10):3199-204. DOI: 10.1245/s10434-013-3118-z. View

11.

Tran H, Pack D, Mylander C, Martino L, Rosman M, Tafra L . Ultrasound-Based Nomogram Identifies Breast Cancer Patients Unlikely to Harbor Axillary Metastasis: Towards Selective Omission of Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2020; 27(8):2679-2686. DOI: 10.1245/s10434-019-08164-3. View

12.

Giuliano A, Ballman K, McCall L, Beitsch P, Brennan M, Kelemen P . Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017; 318(10):918-926. PMC: 5672806. DOI: 10.1001/jama.2017.11470. View

13.

Joh J, Han G, Kiluk J, Laronga C, Khakpour N, Lee M . Indications for axillary ultrasound use in breast cancer patients. Clin Breast Cancer. 2012; 12(6):433-7. DOI: 10.1016/j.clbc.2012.09.009. View

14.

Lambert A, Pattabiraman D, Weinberg R . Emerging Biological Principles of Metastasis. Cell. 2017; 168(4):670-691. PMC: 5308465. DOI: 10.1016/j.cell.2016.11.037. View

15.

Boileau J, Poirier B, Basik M, Holloway C, Gaboury L, Sideris L . Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014; 33(3):258-64. DOI: 10.1200/JCO.2014.55.7827. View

16.

Zhang H, Sui X, Zhou S, Hu L, Huang X . Correlation of Conventional Ultrasound Characteristics of Breast Tumors With Axillary Lymph Node Metastasis and Ki-67 Expression in Patients With Breast Cancer. J Ultrasound Med. 2018; 38(7):1833-1840. DOI: 10.1002/jum.14879. View

17.

Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N . Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996; 276(22):1818-22. View

18.

Xie F, Zhang D, Cheng L, Yu L, Yang L, Tong F . Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer. World J Surg Oncol. 2015; 13:319. PMC: 4653941. DOI: 10.1186/s12957-015-0736-x. View

19.

Ashikaga T, Krag D, Land S, Julian T, Anderson S, Brown A . Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010; 102(2):111-8. PMC: 3072246. DOI: 10.1002/jso.21535. View

20.

Cyr A, Tucker N, Ademuyiwa F, Margenthaler J, Aft R, Eberlein T . Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound. J Am Coll Surg. 2016; 223(2):399-407. PMC: 4961625. DOI: 10.1016/j.jamcollsurg.2016.04.048. View